Mobile Health and Wearable Devices for Diabetes Complication Management

Summary

The value of intelligent lifestyle intervention for T2D and its complications has been initially explored, but evidence-based support for the effectiveness of related AI risk prediction models and intervention models remains to be confirmed. The primary objective of this study is to verify the effectiveness of an AI model for predicting the risk of T2D complications based on phenotype, laboratory indicators and wearable device indicators, and to explore the effect and applicability of an intelligent lifestyle intervention model combining wearable devices and smartphones in preventing T2D complications.

Conditions

• Diabetes Mellitus Type 2
• Diabetes Mellitus Complications

Interventions

OTHER

Device: No specific devices

Routine doctor-patient interaction.

OTHER

Device: CGM,CGM management platform

Wearable monitoring + CGM management platform-assisted administration

OTHER

Device: "Professor Tang" WeChat Mini-program

Mini-program-assisted health management

OTHER

Device: CGM, Smart Bracelet, "Professor Tang" WeChat Mini-program

Wearable monitoring + mini-program integrated management

Sponsors & Collaborators

• First Hospital of China Medical University

  collaborator OTHER

• The First Affiliated Hospital with Nanjing Medical University

  collaborator OTHER

• First Affiliated Hospital of Harbin Medical University

  collaborator OTHER

• Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  collaborator OTHER

• First Affiliated Hospital of Kunming Medical University

  collaborator OTHER

• Tianjin Medical University Chu Hsien-I Memorial Hospital

  collaborator UNKNOWN

• Shanghai 6th People's Hospital

  collaborator OTHER

• Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus

  collaborator UNKNOWN

• Sinocare

  collaborator INDUSTRY

• Second Xiangya Hospital of Central South University

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-10-01

Primary Completion

2026-10-01

Completion

2027-10-01

Countries

• China

Study Locations